AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,500.00p
   
  • Change Today:
    196.00p
  • 52 Week High: 12,210.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.69m
  • Volume: 1,352,155
  • Market Cap: £178,330m
  • RiskGrade: 123

Latest ShareCast News

EU approves AstraZeneca's Tezspire to treat nasal conditions

By Frank Prenesti

Date: Monday 22 Sep 2025

(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.

AstraZeneca ShareCast News

London close: Stocks mixed ahead of central bank... 15-Sep-2025 ShareCast
AstraZeneca to pause £200m Cambridge investment,... 15-Sep-2025 ShareCast
London close: Stocks fall on Trump's latest tari... 01-Aug-2025 ShareCast
London close: Stocks mixed on corporate updates,... 29-Jul-2025 ShareCast
Astrazeneca H1 gross profits up 10pc as 'strong ... 29-Jul-2025 ShareCast

AstraZeneca Regulatory News

Koselugo recommended for EU approval 22-Sep-2025 07:05 RNS
Tezspire Recommended for Approval in EU for CRSwNP 22-Sep-2025 07:00 RNS
Saphnelo met primary endpoint in TULIP-SC 17-Sep-2025 07:05 RNS
Update on RESOLUTE Phase III trial 17-Sep-2025 07:00 RNS
Total Voting Rights 01-Sep-2025 15:00 RNS

AstraZeneca Newspaper Links

Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian
Pfizer unlikely to try AstraZeneca takeover agai... 07-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,500.00p
Change Today 196.00p
% Change 1.73 %
52 Week High 12,210.00
52 Week Low 9,667.00
Volume 1,352,155
Shares Issued 1,550.69m
Market Cap £178,330m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 9
Buy 13
Neutral 5
Sell 0
Strong Sell 0
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 22-Sep-2025

Time Volume / Share Price
16:21 0 @ 11,510.00p
16:05 0 @ 11,484.00p
16:22 0 @ 11,504.00p
16:00 0 @ 11,490.00p
16:00 0 @ 11,490.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page